Author:
Khoubnasabjafari Maryam,Samadi Azam,Jouyban Abolghasem
Funder
Tabriz University of Medical Sciences
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. von Winckelmann SL, Spriet I, Willems L (2008) Therapeutic drug monitoring of phenytoin in critically ill patients. Pharmacotherapy 28:1391–1400
2. Soldin SJ, Wang E, Verjee Z, Elin RJ (2003) Phenytoin overview--metabolite interference in some immunoassays could be clinically important. Arch Pathol Lab Med 127:1623–1625
3. Nelson MH, Birnbaum AK, Nyhus PJ, Remmel RP (1998) A capillary GC-MS method for analysis of phenytoin and [13C3]-phenytoin from plasma obtained from pulse dose pharmacokinetic studies1. J Pharm Biomed Anal 17:1311–1323
4. Qu L, Fan Y, Wang W, Ma K, Yin Z (2016) Development, validation and clinical application of an online-SPE-LC-HRMS/MS for simultaneous quantification of phenobarbital, phenytoin, carbamazepine, and its active metabolite carbamazepine 10,11-epoxide. Talanta 158:77–88
5. Anilanmert B, Çavuş F, Narin I, Cengiz S, Sertler Ş, Özdemir AA, Açikkol M (2016) Simultaneous analysis method for GHB, ketamine, norketamine, phenobarbital, thiopental, zolpidem, zopiclone and phenytoin in urine, using C18 poroshell column. J Chromatogr B 1022:230–241
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献